2022 FDA TIDES (Peptides and Oligonucleotides) Harvest

A total of 37 new drug entities were approved in 2022; although that year registered the lowest number of drug approvals since 2016, the TIDES class consolidated its presence with a total of five authorizations (four peptides and one oligonucleotide). Interestingly, 23 out of 37 drugs were first-in-...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Musaimi, Othman, Al Shaer, Danah, Albericio, Fernando, de la Torre, Beatriz G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056021/
https://www.ncbi.nlm.nih.gov/pubmed/36986436
http://dx.doi.org/10.3390/ph16030336

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056021/
https://www.ncbi.nlm.nih.gov/pubmed/36986436
http://dx.doi.org/10.3390/ph16030336

Ejemplares similares